DCGI gives nod to Bharat Biotech to conduct phase I & II Human clinical trials to develop indigenous vaccine for COVID-19
New Delhi, June 30 : The Drug Controller General of India (DCGI) has granted permission to Bharat Biotech International Limited
Read more